These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 33446889)
1. SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human pulmonary disease in COVID-19. Arce VM; Costoya JA Cell Mol Immunol; 2021 Mar; 18(3):513-514. PubMed ID: 33446889 [No Abstract] [Full Text] [Related]
2. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice. Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780 [TBL] [Abstract][Full Text] [Related]
3. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus. Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775 [TBL] [Abstract][Full Text] [Related]
4. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice. Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A mBio; 2021 Apr; 12(2):. PubMed ID: 33879586 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Zhang L; Zhou L; Bao L; Liu J; Zhu H; Lv Q; Liu R; Chen W; Tong W; Wei Q; Xu Y; Deng W; Gao H; Xue J; Song Z; Yu P; Han Y; Zhang Y; Sun X; Yu X; Qin C Signal Transduct Target Ther; 2021 Sep; 6(1):337. PubMed ID: 34489403 [TBL] [Abstract][Full Text] [Related]
6. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection. Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains. Radvak P; Kwon HJ; Kosikova M; Ortega-Rodriguez U; Xiang R; Phue JN; Shen RF; Rozzelle J; Kapoor N; Rabara T; Fairman J; Xie H Nat Commun; 2021 Nov; 12(1):6559. PubMed ID: 34772941 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein. Khaddaj-Mallat R; Aldib N; Bernard M; Paquette AS; Ferreira A; Lecordier S; Saghatelyan A; Flamand L; ElAli A Neurobiol Dis; 2021 Dec; 161():105561. PubMed ID: 34780863 [TBL] [Abstract][Full Text] [Related]
9. Using Genetics To Dissect SARS-CoV-2 Infection. Brest P; Mograbi B; Hofman P; Milano G Trends Genet; 2021 Mar; 37(3):203-204. PubMed ID: 33309104 [TBL] [Abstract][Full Text] [Related]
10. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice. Kumari P; Rothan HA; Natekar JP; Stone S; Pathak H; Strate PG; Arora K; Brinton MA; Kumar M Viruses; 2021 Jan; 13(1):. PubMed ID: 33477869 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis. Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423 [TBL] [Abstract][Full Text] [Related]
12. Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein. Heinzelman P; Romero PA PLoS One; 2021; 16(5):e0251585. PubMed ID: 33979391 [TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis of APP Expression Modulated by SARS-CoV-2 Infection via the ACE2 Receptor. Caradonna A; Patel T; Toleska M; Alabed S; Chang SL Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163117 [TBL] [Abstract][Full Text] [Related]
14. Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein. Calcagnile M; Forgez P; Iannelli A; Bucci C; Alifano M; Alifano P Biochimie; 2021 Jan; 180():143-148. PubMed ID: 33181224 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related]
16. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
17. Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses. Ye C; Chiem K; Park JG; Silvas JA; Morales Vasquez D; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Kobie JJ; Walter MR; de la Torre JC; Martinez-Sobrido L Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34561300 [TBL] [Abstract][Full Text] [Related]
18. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice. Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370 [TBL] [Abstract][Full Text] [Related]
19. Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice model. Vergara A; Jacobs-Cachá C; Molina-Van den Bosch M; Domínguez-Báez P; Benito B; García-Carro C; Serón D; Soler MJ Mol Cell Endocrinol; 2021 Jun; 529():111263. PubMed ID: 33811970 [TBL] [Abstract][Full Text] [Related]